We demonstrated that expression of LOX, the gene with the highest level of induction in biomimetic scaffolds, has prognostic value in breast cancer patients, being significantly higher in the primary tumor of patients that developed metastatic disease. The gene discussed is LOX; the disease is metastatic neoplasm.